Advanced search
Publication Cover
Immunological Medicine Volume 47, 2024 - Issue 1
Submit an article Journal homepage
1,813
Views
2
CrossRef citations to date
0
Altmetric
Review Articles

A new therapeutic target for systemic lupus erythematosus: the current landscape for drug development of a toll-like receptor 7/8 antagonist through academia-industry-government collaboration

Yoshiya Tanakaa University of Occupational and Environmental Health, Japan, Kitakyushu, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0807-7139View further author information
ORCID Icon,
Fumitoshi Tagob Eisai Co., Ltd, Tokyo, JapanView further author information
,
Naoto Yamakawab Eisai Co., Ltd, Tokyo, JapanView further author information
,
Mari Aokib Eisai Co., Ltd, Tokyo, JapanView further author information
,
Takuya Yagic Eisai Inc, Nutley, USAView further author information
&
Shizuo Akirad Laboratory of Host Defense, Immunology Frontier Research Center, Osaka University, Osaka, JapanView further author information
Pages 24-29 | Received 08 Aug 2023, Accepted 23 Sep 2023, Published online: 29 Sep 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.